In DepthOncology

Vitamin C could target some common cancers

See allHide authors and affiliations

Science  06 Nov 2015:
Vol. 350, Issue 6261, pp. 619
DOI: 10.1126/science.350.6261.619

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Decades ago, Nobel Prize–winning chemist Linus Pauling was relegated to the fringes of medicine after championing the idea that vitamin C could combat a host of medical conditions, including cancer. Now, a study published online this week by Science reports that vitamin C can kill tumor cells that carry a common cancer-causing mutation and, in mice, can curb the growth of tumors with the mutation. If the findings hold up in people, researchers may have found a way to treat a large swath of tumors that have lacked effective drugs. Because high dose vitamin C is already known to be safe, clinical trials to test this idea could move ahead quickly.